Office (Mon - Fri)

08:00 am - 17:00 pm

Call Us

+62 818-880308

Email Us

info@hanamari.co.id

hotel_class

Product Quality

Our product selection policy prioritizes quality and cutting-edge technology.

query_stats

Marketing Strategy

Our Marketing strategy targets both private and public hospitals.

support_agent

Consultative Sales

Our sales approach around consultative selling for the best Choice.

Image

Welcome to PT Hanamari Mitra Medika

Partner for Future Healthines

PT Hanamari Mitra Medika is a distinguished medical equipment distribution company, specializing in Radiology, ICU, PICU and NICU equipment. Our inception was driver by a pressing need in the market. Presently, there is a lack of dedicated distributors focused on these crucial medical equipment categories. this lack of specialization has led to uncertainly amaong consumers, who often consumers, who often question the quality of after-sales service provided by these other distributors. in response to this, PT Hanamari Mitra Medika aspires to be trusted partner for growth and development.

Vision

Through innovation, ingenuity and dedication to our customers, our vision is to be diversified healthcare caompany focused in providing best in class products and service which improve patient care and enhance the quality of people's lives.

Mission

As a Medical device distributor our mission is providing our clients with the highest quality products to improve patient care across indonesia. we aim to provide training and education, utilising the latest innovative technologies to support our customer through the patient journey, we provide ourselves in service excellence

INOwill Nitric Oxide Generator and Delivery System

Nitric Oxide Generator (Reactant Cell)

Tube Accessories (Adult) for INOwill N200

Flow Sensor Non Disinfectable for INOwill N200

Flow Sensor Disinfectable for INOwill N200

Microwave Ablation Generator KY-2000-A

SureTip

ThyTip

XphereTip

Tube Accesories (Neonates) for INOwill N200

EVsim

MINDRAY DIAGNOSTIC ULTRASOUND SYSTEM TEX20 WITH 3 PROBE

Microvawe Ablation Generator KY-2100-A

FlexTip

After Sales Service

We Provide Service

Image

Focusing exclusively on Radiology, ICU, PICU, and NICU equipment, PT Hanamari Mitra Medika iss unwavering in its commitment to provide top-tier support to our clients. This includes guaranteeing the availability of products and their spare parts.

Availability of Stock and Spare Part

+
Image

In pursuit of customer satisfaction, PT hanamari Mitra Medika prioritizes preemptive measures over corrective ones. To achieve this, we have dedicated technicians for routine maintenance services to prevent any downtime for our clients.

Preemptive Measures

+
Image

To mitigaet unexpected downtime, we go the extra mile providig backup units. this ensures that our clients can continue operating their equipment seamlessly even in the face of unforeseen issues.

Back-up Unit

+
Image

Our founders, being doctors deeply attuned to patient safety, understand the importance of unwavering service. Therefore, we pledge to be available for contact 24 hours a day, 7 days a week, including holidays.

24/7 Service

+

Board of Directors

Our founding fathers are distinguished doctors with extensive experience in Radiology and interventional Radiology. Their wealth of experience is a cornerstone fot PT. Hanamari Mitra Medika, ensuring that we deliver the right products and services tailored to the unique needs of hospitals.

Frequently Asked Question

You May Ask

Thyroid cancer is responsible for 586,000 cases worldwide, ranking in 9th place for incidence in 2020. The global incidence rate in women of 10.1 per 100,000 is 3-fold higher than that in men. Mortality rates from the disease are much lower, with rates of 0.5 per 100,000 in women and 0.3 per 100,000 in men and an estimated 44,000 deaths in both sexes combined [1].
According to 2020 European Thyroid Association Clinical Practice Guideline and European Thyroid Association and Cardiovascular and Interventional Radiological Society of Europe 2021 Clinical Practice Guideline, due to the frequent indolent nature, cost, and risk of surgery, image-guided thermal ablation (TA) procedures like microwave ablation has been proposed as non-surgical treatment options for around 3 decades [2][3].
As an alternative option, Image guided Microwave Ablation technology has been widely recommended and used as clinical treatment for thyroid diseases. It is mainly indicated for the treatment of thyroid nodules and thyroid cancers like papillary thyroid microcarcinomas (PTMCs).
Approximately, 2.2 million new cases of lung cancer and 1.8 million lung cancer related deaths were reported in 2020 worldwide. Although the incidence of lung cancer ranks the second in the world, the mortality rate is the highest [1].
By 2022, China and the USA are expected to have approximately 870,982 and 238,032 new lung cancer cases, and 766,898 and 144,913 lung cancer deaths, respectively [2].
For early-stage NSCLC, surgical resection with curative intent comprises the primary therapy, however, approximately 60% of lung cancers cannot be resected surgically due to various reasons. Therefore, microwave ablation, a precise minimally invasive technique, has been applied on treating early-stage lung cancer [3].
As an alternative option, Image guided Microwave Ablation technology has been widely recommended and used as clinical treatment for lung diseases. According to the Lung Clinical Practise Guidelines [3] and Expert Consensus [4], It’s mainly indicated for the treatment of pulmonary subsolid nodules as well as primary and metastatic lung tumors.
Liver cancer is the sixth most commonly diagnosed cancer and the third leading cause of cancer death world- wide in 2020, with approximately 906,000 new cases and 830,000 deaths. Primary liver cancer includes hepatocellular carcinoma (HCC) (comprising 75%-85% of cases) and intrahepatic cholangiocarcinoma (10%-15%), as wel as other rare types [1].
Traditionally, surgical resection is the reference standard for treatment of patients with hepatic malignancy, however, only a small proportion of patients have the chance to be candidates [2].
As an minimal invasive therapy, image guided Microwave Ablation technology has been widely used as a clinical treatment option for tumors including liver tumor in China [3] and Asia [4]. Microwave Ablation technology has also been recommended by CSCO Guideline (Level of Evidence 1, Recommendation B) [5] and CIRSE Standard Guideline (Level of Evidence 1) [6] as a first line therapy for solitary hepatocellular carcinoma. NCCN Guideline recommend MWA as a suitable option for selected patients (Recommendation 2A) [7].
Kidney cancer is currently the ninth most common cancer in men and the 14th most common in women worldwide. An estimated 431,288 people were diagnosed with kidney cancer in 2020 [1].
Renal cell carcinoma (RCC) comprises more than 90% of kidney cancer. The traditional standard of care for clinically localised RCC is surgical resection. However, not all of patients have the chance to be candidates due to various reasons.
Microwave ablation, as a minimally invasive ablative technologies have emerged as promising treatment options for clinically localised RCC to reduce procedural morbidity while maintaining equivalent oncologic effectiveness with surgery [2]. In China's guidelines, it is mainly indicated for use to treat kidney tumor with a maximum of 3 lesions and a single lesion with a diameter ≤ 4cm (T1a) (Level of Evidence 2-4) [3].
The microwave ablation therapy is also recommended by ACTA Guidelines for RCC (Recommendation B-C) [4] and the EAU Guidelines on RCC [5].
Breast lesions are common and occur frequently in clinical practice. They are prone to various abnormalities and disorders because mammary glands are regulated by endocrine factors [1]. Most breast lesions are benign, only 1%~2% are malignant [2].
Benign breast lesions are the outcomes of proliferation of ductal or lobular tissue that are manifested by the presence of palpable lumps or masses. lts volume will continue to increase, affecting the quality of life for women [3].
The clinical management of breast lesions mainly includes follow-up observation, lesion biopsy, and surgical intervention [1]. So far, surgical intervention, including the breast-conserving surgery(BCS), is an effective way to treat this disease. Yet, some patients are intolerant to surgery because of their poor physical condition and 10% to 40% of patients treated with BCS reported being unsatisfied with cosmetic results for the reason of scar formation and breast asymmetry [3].
In this situation, minimally invasive techniques, such as microwave ablation shows great value to treat benign breast lesions [3].
Uterine fibroids are benign tumors that occur most commonly (70-80%) in women of childbearing age [1] . Fibroids impose a significant psychological burden on affected women. Patients with symptoms often must be treated to alleviate those symptoms [2].
Treatment options for fibroids include hysterectomy, myomectomy, hysteroscopic resection and minimally invasive approaches. Surgical treatment remains the reference standard in the treatment of uterine fibroids; however, it may cause severe trauma and undesirable comorbidity [3].
Actually, not every patient is suitable for the surgical treatment. And improvement in quality of life is a major concern for women evaluating options for fibroids treatment [4]. Thus, increasing attention has been paid to the study of minimally invasive or non-invasive therapies with uterine preservation such as Microwave Ablation [5].
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Phasellus nec pretium mi. Curabitur facilisis ornare velit non.
Microwave ablation can generate larger ablation zones in shorter time with less sensibility to heat sink effect.Moreover, MWA radiates all biological issues, such as bone, lung, charred or desiccated tissues. Additionally,multiple antennas can be placed to treat simultaneously for large tumors or multifocal lesion.With CANYON New Generation Microwave Ablation System, the achieved ablation zone can be uniform,homogeneous, and predictable. In addition, a choice of antennas and customized settings provides the user with unique opportunities for clinical diversity during treatment.
- A new portable solid state system to ensure stable microwave output.
- An interactive and sensitive touchscreen with adjustable power, time, and temperature which makes it very user-friendly .
- Continuous and pulsed modes are available for different clinical options.
- Innovative interface which allows the user to monitor and provides instant feedback for safe use .
• Patented radiation control technology and fully cooled antenna that guarantees an ultraspherical shape of the ablation zone • Enhanced product safety that gives the benefit of strength and stiffness • New coating which gives the user a perfect and smooth puncture movement, also avoiding tissue adhesion in an efficient way • Echogenic design that gives the user enhanced visibility • Available in 14G and 15G in different lengths
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Phasellus nec pretium mi. Curabitur facilisis ornare velit non.
- China’s first portable NO inhalation therapy device (NMPA Class III certificate).
- Well-integrated functions: gas instant generation, gas delivery & monitoring.
- Approved for adult and pediatric pulmonary arterial hypertension (PAH).
- Used to treat PPHN, PAH, right heart failure, ARDS syndrome, etc. in NICU, ICU, cardiac surgery, emergency room and respiratory departments.
- CE certification in progress; Certified in Indonesia.

Latest News

Latest From Our News

Image

The XII Indonesian Gynecological Endoscopy Society (IGES) Annual National Congress

ByPT Hanamari

At04 Dec, 2025

The 12th Annual National Congress of the Indonesian Gynecological
Endoscopy Society (IGES) be held from 6 – 9 November 2025 in the
culturally rich city of Solo, Central Java. Th...

Image

Penggunaan Microwave Ablation di RSUD dr. Moewardi

ByChaska

At21 Mar, 2025

RSUD Dr. Moewardi baru-baru ini berhasil melaksanakan prosedur operasi ginekologi dengan menggunakan teknologi Microwave Ablation. Inovasi ini memberikan banyak manfaat, di antaranya ...

Image

Meet The Expert-Jakarta

ByHanamari

At20 Mar, 2025

Departemen Ilmu Kesehatan Anak FKUI-RSCM bekerjasama dengan PT. Hanamari Mitra Medika mengadakan Meet The Expert dengan tema: Pulmonary Hypertension in the Intensive Care Unit and Treatment of ...

Image

WORKSHOP RADIOLOGI INTERVENSIONAL

ByHanamari

At11 Mar, 2025

PT Hanamari Mitra Medika mengikuti Workshop Radiologi Intervensional yang diselenggarakan oleh Lembaga Pelatihan Mandiri Radiologi Klinik Indonesia (LPMRKI). Pada 08-09 Maret 2025.

...

Image

IPOKRaTES 2024

ByHanamari

At10 Mar, 2025

PT HANAMARI MITRA MEDIKA mengikuti acara seminar IPOKRaTES yang diselenggarakan oleh dept. Ilmu Kesehatan Anak FK Universitas Udayana/RSUP Prof. Dr. I. G. N. G Ngooerah Denpasar bekerja sama dengan...

Image

10th Asian Conference on Tumor Ablation

Byhanamarian

At20 Feb, 2025

As one of the most influential and largest conference in the field of Tumor Ablation in Asia, it has made great contributions to the education and progression of Ablation Solution in Asia and world...

Load More
WhatsApp

Office Contact

JL Karang Tengah Raya A1

Apple 3 Condovilla GF D11

Lebak Bulus, Cilandak

Jakarta 12440, Indonesia

Sales AREA

location_on Jabodetabek location_on Jawa Barat location_on Jawa Tengah location_on Jawa TImur location_on Medan

Office Links

apartment Administration apartment Accounting apartment Human Resource apartment Employee apartment Jobs Vacancy
PT Hanamari Mitra Medika
keyboard_arrow_up